Finding Solutions to the Latest Challenges in Rx Drug Pricing

With both federal and state law makers engaging in greater scrutiny of prescription drug pricing, now is the time when industry professionals must stay up to date on the latest amendments to government payor programs as well as their impact on the private sector.

Join us in New York City to gain a holistic view of how these government payor programs relate and often intersect with each other.

2024 Conference Co-Chairs
Speaker

Stephen Forster

Partner
Morgan Lewis Bockius LLP

Speaker

Trevor Wear

Partner
Sidley Austin LLP

This Year’s Highlights Include

A leading faculty of experienced practitioners will help you master core drug pricing concepts and calculations, and help you:

  • IRA Implementation State of the Union: A Look Back and A Look Forward into the First Round of Drug Price Negotiations
  • Simplifying Inflation Rebate Penalties Under Medicare Part B and D
  • A Look at PBMs through the Lens of the IRA: Practices and Their Legal Challenges 
  • Examining the Full Impact of CMS’ Ground-Shifting New Proposed Medicaid Drug Rebate Program Rule
  • A Manufacturer’s Guide to Critical Drug Pricing and Reimbursement Considerations when Launching New Products
  • Understanding How the Pricing of Biosimilars Affects Government Drug Payor Programs
PRE-CONFERENCE WORKSHOPS

Add more value to your conference experience by signing up for these hands-on and practical workshops.

WORKSHOP A

Government Payor Program 101: Primer on the Pricing Essentials of the Medicare, Medicaid, and PHS 340B Program

March 19, 2024
9:30 am – 12:30 pm

WORKSHOP B

Data Package Master Class: A Guide for Manufacturers on Building Sufficient Data Packages for Drug Price Negotiations

March 19, 2024
1:30 – 4:30 pm

Workshops are offered in-person only

A MUST ATTEND EVENT FOR
Pharmaceutical Companies
  • Corporate Counsel/General Counsel
  • Vice Presidents, Officers, Directors and Managers for:
    • Pricing, Pricing Strategy, Pricing Analytics
    • Contracts and Reimbursement
    • Managed Care
    • Government Programs
    • Medicaid/Medicare Rebates
    • Finance/Accounting/Audit
    • Government Affairs
    • Marketing
  • Compliance Officers
Law Firms
  • Attorneys with practice areas in:
    • Pharmaceuticals
    • Healthcare
    • Food & Drug
PBMs
  • Corporate Counsel/General Counsel
  • Vice Presidents, Officers, Directors and Managers for:
    • Contract Management
    • Network Pharmacy
    • Retail Pharmacy Operations
    • Government Programs
    • Pricing and Operations
    • Clinical Operations
    • Industry Relations/Government Affairs
  • Financial Analysts
Pharmacies
  • Corporate Counsel/General Counsel
  • Vice Presidents, Officers, Directors and Managers for:
    • Pricing
    • Business Development
Plans
  • Corporate Counsel/General Counsel
  • Vice Presidents, Officers, Directors and Managers for:
    • Pharmacy Networks
    • Pharmaceutical Contracting
    • Clinical
    • Pharmacy Services
WHAT PAST ATTENDEES SAY
Quote Icon

Excellent and fully capable list of speakers.

VP US Commercial Legal, Lundbeck LLC
Quote Icon

All encompassing overview of government programs and current issues.

Director, Pricing and Contracts, Horizon Pharmaceuticals
CLE/CPE Accreditation

Accreditation will be sought in those jurisdictions requested by the registrants which have continuing education requirements. This course is identified as non-transitional for the purposes of CLE accreditation.

Learn More
RELATED EVENTS
Event Thumbnail Image
Event Thumbnail Image